Page last updated: 2024-12-10

angiotensin iii, 5-ile-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3082042
CHEMBL ID1702539
CHEBI ID89666
SCHEMBL ID9010604
MeSH IDM0079579

Synonyms (26)

Synonym
1-de-l-aspartic acid-5-l-isoleucine-angiotensin ii
angiotensin iii, 5-ile-
unii-xh7f04lxtf
angiotensin ii, 1-desaspartyl-5-isoleucine-
5-ile-angiotensin iii
des-asp(1)-(ile(5))-angiotensin ii
xh7f04lxtf ,
NCGC00167131-01
1-desaspartyl-5-isoleucine angiotensin ii
(2s)-2-[[(2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amin
chebi:89666 ,
CHEMBL1702539
cas_12687-51-3
bdbm85557
angiotensin iii trifluoroacetate salt hydrate
AKOS024456669
SCHEMBL9010604
QMMRCKSBBNJCMR-KMZPNFOHSA-N
(2s)-2-{[(2s)-1-[(2s)-2-[(2s,3s)-2-[(2s)-2-[(2s)-2-[(2s)-2-amino-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic
angiotensin iii (h-l-arg-l-val-l-tyr-l-ile-l-his-l-pro-l-phe-oh)
mfcd00167500
des-asp-1-angiotensin ii
(s)-2-((s)-1-((6s,9s,12s,15s,18s)-18-((1h-imidazol-4-yl)methyl)-1,6-diamino-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxamido)-3-phenylpropanoic acid
CS-0044838
HY-P1540
angiotensin iii, human, mouse
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
peptideAmide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Renin-angiotensin pathway (COVID-19 Disease Map)116
Renin-angiotensin system110

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency31.62280.251215.843239.8107AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID39185In vitro antagonist activity against Angiotensin II receptor was measured in the rabbit aorta strip assay1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
AID167773In vitro agonist angiotensin II like activity was measured in the rabbit aorta strip assay1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
AID1146282Relative binding affinity of the compound assessed as ratio of [Asp1,Ile5]angiotensin II ED50 to compound ED50 for angiotensin 2 receptor in rabbit aortic strips1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Biologically active derivatives of angiotensin for labeling cellular receptors.
AID169066In vivo agonist angiotensin II like activity was measured in rat blood pressure assay1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]